Weekly CEO Buys Highlight: Saul Centers Inc, Spartech Corp, Harvard Bioscience Inc, Rural/Metro Corp, Dr Pepper Snapple GP
Saul Centers Inc. (BFS): CEO, 10% Owner B Francis Saul Ii Bought 32,003 Shares
CEO, 10% Owner of Saul Centers Inc. (BFS) B Francis Saul Ii bought 32,003 shares during the past week at an average price of $42.55. SAUL CENTERS, INC. is a real estate investment trust which is engaged in the management and development of the shopping center business of the Saul Organization. Saul Centers Inc. has a market cap of $780.7 million; its shares were traded at around $42.55 with and P/S ratio of 4.8. The dividend yield of Saul Centers Inc. stocks is 3.4%. Saul Centers Inc. had an annual average earning growth of 0.7% over the past 10 years.
BFS recently reported its second quarter results. Total revenue for the three months ended June 30, 2010 increased 1.8% to $40,121,000 compared to $39,416,000 for the three months ended June 30, 2009. Operating income increased 1.4% to $10,717,000 for the 2010 Quarter compared to $10,574,000 for the 2009 Quarter.
Sell: Sr. Vice President-CFO Scott V Schneider sold 5,000 shares of BFS stock on 09/14/2010 at the average price of 44.05. Scott V Schneider owns at least 10,152 shares after this. The price of the stock has decreased by 3.41% since.
Spartech Corp. (SEH): President and CEO Victoria M Holt Bought 72,037 Shares
President and CEO of Spartech Corp. (SEH) Victoria M Holt bought 72,037 shares on 09/14/2010 at an average price of $8. SPARTECH CORP. is in the plastics processing business, with its two lines of business being: Extruded Sheet & Rollstock - which sells its products to various manufacturers who use plastic components in their industrial products. Spartech Corp. has a market cap of $247.3 million; its shares were traded at around $8 with a P/E ratio of 20.5 and P/S ratio of 0.2.
Spartech recently reported its third quarter 2010 results. Net sales were $269.6 million, up 17% from the prior year third quarter, reflecting a 7% increase in volumes sold and the pass through of higher raw material costs. Although the company experienced improved sales volumes in many markets, the overall market recovery is slower than expected and markets such as domestic construction and recreation and leisure remain weak.
Charles Brandes owns 205,690 shares as of 06/30/2010, which accounts for 0.01% of the $15.29 billion portfolio of Brandes Investment.
Buy: Director Jackson W Robinson bought 10,000 shares of SEH stock on 09/13/2010 at the average price of 7.03. Jackson W Robinson owns at least 41,723 shares after this. The price of the stock has increased by 13.8% since. Other insiders have also increased their positions in the company.
Harvard Bioscience Inc. (HBIO): CEO, 10% Owner Chane Graziano Bought 127,634 Shares
CEO, 10% Owner of Harvard Bioscience Inc. (HBIO) Chane Graziano bought 127,634 shares during the past week at an average price of $3.72. HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Harvard Bioscience Inc. has a market cap of $105.5 million; its shares were traded at around $3.72 with a P/E ratio of 12.8 and P/S ratio of 1.2. Harvard Bioscience Inc. had an annual average earning growth of 5% over the past 5 years.
HBIO recently reported its second quarter 2010 results. Revenues for the three months ended June 30, 2010 were $25.9 million, an increase of $7.9 million, or 43.5%, compared to revenues of $18.0 million for the three months ended June 30, 2009. Currency exchange rate changes had a negative 3.6% effect on revenues in the second quarter of 2010 compared with the second quarter of 2009, and the Company's Denville Scientific business, which we acquired in September 2009, had a positive 36.1% effect on revenues. Excluding the effects of currency exchange rate changes and the Denville acquisition, the Company's organic revenue growth for the second quarter of 2010 was 11.0% over the same period in the previous year.
Rural/Metro Corp. (RURL): President and CEO Michael P Dimino Bought 48,500 Shares
President and CEO of Rural/Metro Corp. (RURL) Michael P Dimino bought 48,500 shares on 09/13/2010 at an average price of $8.51. Rural/Metro Corp. is a provider of health and safety services, which include ``911`` emergency ambulance and general medical transport services, fire protection services, and other safety and health care related services, to municipal, residential, commercial, and industrial customers. Rural/metro Corp. has a market cap of $215 million; its shares were traded at around $8.51 with a P/E ratio of 16.4 and P/S ratio of 0.4.
RURL recently reported its fiscal 2010 full year and 4th quarter results. For the fiscal year ended June 30, 2010, the Company generated net revenue of $530.8 million, an increase of 7.9% or $39.0 million, compared to $491.8 million for the same prior-year period. Ambulance services revenue was $457.8 million, an increase of 9.6% or $40.0 million, compared to $417.8 million for the same prior-year period. The increase was primarily attributable to $37.4 million in same-service-area revenue growth, which was driven by reductions in uncompensated care, rate increases and a 4.1% increase in ambulance transport volume, as well as $2.6 million from new contract growth. Other services revenue was $72.9 million, a decrease of 1.4% or $1.0 million, compared to $73.9 million for the same prior-year period.
Buy: Director A Conrad Conrad bought 10,000 shares of RURL stock on 06/14/2010 at the average price of 7.86. A Conrad Conrad owns at least 59,500 shares after this. The price of the stock has increased by 8.27% since. There are mixed trades from other insiders.
DR PEPPER SNAPPLE GP (DPS): President & CEO Larry D Young Bought 5,000 Shares
President & CEO of DR PEPPER SNAPPLE GP (DPS) Larry D Young bought 5,000 shares on 09/10/2010 at an average price of $35.31. DR PEPPER SNAPPLE Group is one of the largest beverage companies in the Americas. Dr Pepper Snapple Gp has a market cap of $8.43 billion; its shares were traded at around $35.31 with a P/E ratio of 16.7 and P/S ratio of 1.5. The dividend yield of Dr Pepper Snapple Gp stocks is 2.8%.
DPS recently reported second quarter 2010 diluted earnings of $0.74 per share compared to $0.62 per share in the prior year period. Year-to-date, the company reported earnings of $1.09 per diluted share compared to $1.14 per share in the prior year period. Excluding a separation-related foreign deferred tax charge in the current year and a net gain on certain distribution agreement changes in the prior year, the company earned $1.14 per diluted share compared to $0.99 in the prior year-to-date period.
Whitney Tilson bought 5,400 shares in the quarter that ended on 06/30/2010, which is 0.09% of the $223 million portfolio of T2 Partners Management, LP. George Soros owns 27,300 shares as of 06/30/2010, a decrease of 26.02% of from the previous quarter. This position accounts for 0.03% of the $3.31 billion portfolio of Soros Fund Management LLC. Robert Olstein owns 205,000 shares as of 06/30/2010, a decrease of 40.58% of from the previous quarter. This position accounts for 1.6% of the $479 million portfolio of Olstein Financial Alert Fund.
Buy: Executive Vice President & CFO Martin M Ellen bought 2,000 shares of DPS stock on 09/10/2010 at the average price of 34.91. Martin M Ellen owns at least 12,000 shares after this. The price of the stock has increased by 1.15% since. There are mixed trades from other insiders.